Exploring the Effects of Lactobacillus Paracasei PS23 on Workplace-related Stress Symptoms Among Office Workers
Launched by MACKAY MEMORIAL HOSPITAL · Apr 12, 2023
Trial Information
Current as of April 26, 2025
Terminated
Keywords
ClinConnect Summary
There is still a lack of research to explore the interaction between high-pressure workers and probiotics to improve the intestinal microbiota and further affect its relationship with sleep, inflammation, and anti-oxidation, and further studies are still needed to confirm the clinical effect. A total of 120 subjects are expected to be recruited over a 3-year period starting after IRB approval, divided into two groups of 60 subjects, receiving PS23 or placebo, and completing a 6-week trial period.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Administrative staff of JARLLYTEC CO., LTD.
- • 2. Age 20-65 years old
- • 3. Those who feel that they are in a medium to high stress situation
- Exclusion Criteria:
- • 1. Have taken antibiotics within one month or are receiving antibiotic treatment
- • 2. Have taken probiotic products within two weeks (excluding yogurt, yogurt, Yakult and other related foods)
- • 3. have a history of cancer
- • 4. Those who are allergic to lactic acid bacteria products
- • 5. Those who are currently taking medication for acute illness, mental illness or sleep disorder
- • 6. Pregnant or breastfeeding
- • 7. The project host judges that it is not suitable to participate in the researcher
About Mackay Memorial Hospital
Mackay Memorial Hospital is a leading healthcare institution dedicated to advancing medical science through innovative clinical research. With a commitment to patient-centered care, the hospital actively sponsors and conducts clinical trials across various therapeutic areas, aiming to develop new treatment options and improve health outcomes. Boasting a team of experienced researchers and healthcare professionals, Mackay Memorial Hospital adheres to rigorous ethical standards and regulatory guidelines, ensuring the safety and well-being of participants while contributing to the global body of medical knowledge. Its collaborative approach fosters partnerships with academic institutions and industry leaders, positioning it as a key player in the advancement of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported